Clinical validation of a novel real-time human papillomavirus assay for simultaneous detection of 14 high-risk HPV type and genotyping HPV type 16 and 18 in China

[1]  J. Berkhof,et al.  Clinical Validation of the HPV-Risk Assay, a Novel Real-Time PCR Assay for Detection of High-Risk Human Papillomavirus DNA by Targeting the E7 Region , 2014, Journal of Clinical Microbiology.

[2]  J. Laudadio.  Human Papillomavirus Detection: Testing Methodologies and Their Clinical Utility in Cervical Cancer Screening , 2013, Advances in anatomic pathology.

[3]  M. Schiffman,et al.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer , 2012 .

[4]  C. Trimble,et al.  New technologies for cervical cancer screening. , 2012, Best practice & research. Clinical obstetrics & gynaecology.

[5]  Wengao Chen,et al.  Epidemiologic Characterization of Human Papillomavirus Infection in Rural Chaozhou, Eastern Guangdong Province of China , 2012, PloS one.

[6]  M Arbyn,et al.  Worldwide burden of cervical cancer in 2008. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  Alan D. Lopez,et al.  Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis , 2011, The Lancet.

[8]  T. Iftner,et al.  Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. , 2010, Journal of the National Cancer Institute.

[9]  J. Dillner,et al.  Global Proficiency Study of Human Papillomavirus Genotyping , 2010, Journal of Clinical Microbiology.

[10]  J. Cuzick,et al.  Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. , 2010, The Lancet. Oncology.

[11]  A. Burchell,et al.  Epidemiology of Mucosal Human Papillomavirus Infection and Associated Diseases , 2009, Public Health Genomics.

[12]  K. Lakshmaiah,et al.  HPV screening for cervical cancer in rural India. , 2009, The New England journal of medicine.

[13]  J. W. Kim,et al.  Current status of gynecological cancer in China. , 2009, Journal of gynecologic oncology.

[14]  J. Cuzick,et al.  Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older , 2009, International journal of cancer.

[15]  C. Wheeler,et al.  New technologies in cervical cancer screening. , 2008, Vaccine.

[16]  Min Lin,et al.  Genital human papillomavirus screening by gene chip in Chinese women of Guangdong province , 2008, The Australian & New Zealand journal of obstetrics & gynaecology.

[17]  J. Berkhof,et al.  Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial , 2007, The Lancet.

[18]  M. Schiffman,et al.  The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays. , 2007, American journal of clinical pathology.

[19]  David R. Scott,et al.  The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. , 2005, Journal of the National Cancer Institute.

[20]  J. Dungan.  Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme , 2011 .

[21]  Hagerstoten.  American society for colposcopy and cervical pathology. , 1999, Journal of lower genital tract disease.

[22]  American society for colposcopy and cervical pathology. , 1997, Journal of lower genital tract disease.